1.Karim SA, Baxter C, Frohlich J, Karim QA. The need for multipurpose prevention technologies in sub-Saharan Africa. Bjog. 2014;121 Suppl 5:27–34. https://doi.org/10.1111/1471–0528.12842.
2.Ameyaw EK, Budu E, Sambah F, Baatiema L, Appiah F, Seidu A-A, et al. Prevalence and determinants of unintended pregnancy in sub-Saharan Africa: A multi-country analysis of demographic and health surveys. PLoS ONE. 2019;14(8):e0220970. https://doi.org/10.1371/journal. pone.0220970.
4.Kharsany AB, Karim QA. HIV infection and AIDS in sub-Saharan Africa: current status, challenges and opportunities. Open AIDS J. 2016;10:34–48. https://doi.org/10.2174/1874613601610010034.
5.Hubacher D, Mavranezouli I, McGinn E. Unintended pregnancy in sub-Saharan Africa: magnitude of the problem and potential role of contraceptive implants to alleviate it. Contraception. 2008;78(1):73–8. https://doi.org/10.1016/j.contraception.2008.03.002.
6.United Nations, Department of Economic and Social Affairs, Population Division. Estimates and projections of family planning indicators 2019. 2019. https://www.un.org/en/development/desa/population/publications/pdf/family/Figure_Model-based_estimates_Countries_2019.pdf. Accessed 7 Sept 2019.
7.Pazol K, Kramer MR, Hogue CJ. Condoms for dual protection: patterns of use with highly effective contraceptive methods. Public Health Rep. 2010;125(2):208–17. https://doi.org/10.1177/003335491012500209.
8.Gebrehiwot SW, Azeze GA, Robles CC, Adinew YM. Utilization of dual contraception method among reproductive age women on antiretroviral therapy in selected public hospitals of Northern Ethiopia. Reprod Health. 2017;14(1):125. https://doi.org/10.1186/s12978–017–0390–6.
9.Maticka-Tyndale E. Condoms in sub-Saharan Africa. Sex Health. 2012;9(1):59–72. https://doi.org/10.1071/SH11033.
10.Kraft JM, Galavotti C, Carter M, Jamieson DJ, Busang L, Fleming D, et al. Use of dual protection in Botswana. Stud Fam Plann. 2009;40(4):319–28. https://doi.org/10.1111/j.1728–4465.2009.00214.x.
11.Lopez LM, Stockton LL, Chen M, Steiner MJ, Gallo MF. Behavioral interventions for improving dual-method contraceptive use. Cochrane Database Syst Rev. 2014;30(3): Cd010915. https://doi.org/10.1002/14651858.CD010915.pub2.
12.O’Leary A. Are dual-method messages undermining STI/HIV prevention? Infect Dis Obstet Gynecol. 2011:691210. http://dx.doi.org/10.1155/2011/691210.
13.Eisenberg DL, Allsworth JE, Zhao Q, Peipert JF. Correlates of dual-method contraceptive use: an analysis of the National Survey Of Family Growth (2006–2008). Infect Dis Obstet Gynecol. 2012:717163. http://dx.doi.org/10.1155/2012/717163.
14.Mulongo AM, Lihana RW, Githuku J, Gura Z, Karanja S. Factors associated with uptake of dual contraception among HIV-infected women in Bungoma County, Kenya: a cross-sectional study. Pan Afr Med J. 2017;28 Suppl 1:2. https://www.dx.doi.org/10.11604/pamj.supp.2017.28.1.9289.
15.MacPhail C, Pettifor A, Pascoe S, Rees H. Predictors of dual method use for pregnancy and HIV prevention among adolescent South African women. Contraception. 2007;75(5):383–9. https://doi.org/10.1016/j.contraception.2006.12.020.
16.Ott MA, Adler NE, Millstein SG, Tschann JM, Ellen JM. The trade-off between hormonal contraceptives and condoms among adolescents. Perspect Sex Reprod Health. 2002;34(1):6–14. https://doi.org/10.1363/3400602.
17.Kosugi H, Shibanuma A, Kiriya J, Wafula SW, Jimba M. Consistent condom use among highly effective contraceptive users in an HIV-endemic area in rural Kenya. PLoS One. 2019;14(5):e0216208. https://doi.org/10.1371/journal.pone.0216208.
18.Williamson NE, Liku J, McLoughlin K, Nyamongo IK, Nakayima F. A qualitative study of condom use among married couples in Kampala, Uganda. Reprod Health Matters. 2006;14(28):89–98. https://doi.org/10.1177/003335491012500209.
19.Ramjee G, Daniels B. Women and HIV in sub-Saharan Africa. AIDS Res Ther. 2013;10(1):30–6405–10–30. https://doi.org/10.1186/1742–6405–10–30.
20.National Aids Control Council. Kenya HIV Estimates Report, 2015. 2016. http://nacc.or.ke/wp-content/uploads/2016/12/Kenya-HIV-Estimates–2015.pdf. Accessed 7 Sept 2019.
21.El Ayadi AM, Rocca CH, Kohn JE, Velazquez D, Blum M, Newmann SJ, et al. The impact of an IUD and implant intervention on dual method use among young women: Results from a cluster randomized trial. Prev Med.2017;94:1–6. https://doi.org/10.1016/j.ypmed.2016.10.015.
22.Peipert JF, Zhao Q, Meints L, Peipert BJ, Redding CA, Allsworth JE. Adherence to dual-method contraceptive use. Contraception. 2011;84(3):252–8. https://doi.org/10.1016/j.contraception.2011.01.023.
23.Woodsong C, Koo HP. Two good reasons: women’s and men’s perspectives on dual contraceptive use. Soc Sci Med. 1999;49(5):567–80. https://doi.org/10.1016/s0277–9536(99)00060-x.
24.Marsh DR, Schroeder DG, Dearden KA, Sternin J, Sternin M. The power of positive deviance. Bmj. 2004;329(7475):1177–9. https://dx.doi.org/10.1136%2Fbmj.329.7475.1177.
25.Singhal A, Svenkerud PJ. Diffusion of Evidence-based Interventions or Practice-based Positive Deviations. The Journal of Development Communication. 2018;29(2):54–64.
26.Mutowo J, Kasu C. Barriers to use of dual protection among married women in a Suburban setting. Nurs Health Sci. 2015;4(2):51–7. https://doi.org/ 10.9790/1959–04215157.
27.Uganda Bureau of Statistics. Uganda Demographic and Health Survey 2016. 2018. https://www.ubos.org/wp-content/uploads/publications/07_2018UDHS_2016_FInal.pdf. Accessed 8 Sept 2019.
28.Jarolimova J, Kabakyenga J, Bennett K, Muyindike W, Kembabazi A, Martin JN, et al. Contraceptive use following unintended pregnancy among Ugandan women living with HIV. PloS one. 2018;13(10):e0206325. https://doi.org/10.1371/journal.pone.0206325
29.The Uganda Population-Based HIV Impact Assessment. Uganda population-based HIV impact assessment: UPHIA 2016–2017. 2017. https://www.afro.who.int/sites/default/files/2017–08/UPHIA%20Uganda%20factsheet.pdf. Accessed 8 Sept 2019.
30.The Republic of Uganda Ministry of Health. National health facility master list 2018. 2018. https://health.go.ug/sites/default/files/Signed%20n%20final%20mfl.pdf. Accessed 24 Aug 2019.
31.Makerere University School of Public Health. Rapid Assessment of Comprehensive Condom Programming in Uganda. 2015. https://samasha.org/download/Comprehensive-Condom-Programming-Assessment-In-Uganda_Final-Report-October–2015.pdf. Accessed 8 Sept 2019.
32.Sieving RE, McMorris BJ, Beckman KJ, Pettingell SL, Secor-Turner M, Kugler K, et al. Prime Time: 12-month sexual health outcomes of a clinic-based intervention to prevent pregnancy risk behaviors. J Adolesc Health. 2011;49(2):172–9. https://doi.org/10.1016/j.jadohealth.2010.12.002.
33.Zhang J, Pals SL, Medley A, Nichols C, Bachanas P, van Zyl D, et al. Parameters for sample size estimation from a group-randomized HIV prevention trial in HIV clinics in sub-Saharan Africa. AIDS and Behavior. 2014;18(12):2359–65. https://doi.org/10.1007/s10461–013–0631–9.
34.van Breukelen GJ, Candel MJ. Calculating sample sizes for cluster randomized trials: we can keep it simple and efficient! Journal of clinical epidemiology. 2012;65(11):1212–8. https://doi.org/10.1016/j.jclinepi.2012.06.002.
35.Hemming K, Eldridge S, Forbes G, Weijer C, Taljaard M. How to design efficient cluster randomised trials. Bmj. 2017;358:j3064. https://doi.org/10.1136/bmj.j3064.
36.World Health Organization, The INFO Project at the Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (JHU/CCP). Decision-making tool for family planning clients and providers. 2005. http://www.who.int/reproductive-health/family_planning/tool.html. Accessed 8 Sept 2019.
37.Ewing AC, Kottke MJ, Kraft JM, Sales JM, Brown JL, Goedken P, et al. 2GETHER - The Dual Protection Project: Design and rationale of a randomized controlled trial to increase dual protection strategy selection and adherence among African American adolescent females. Contemp Clin Trials. 2017;54:1–7. https://doi.org/10.1016/j.cct.2016.12.014.
38.Antelman G, Medley A, Mbatia R, Pals S, Arthur G, Haberlen S et al. Pregnancy desire and dual method contraceptive use among people living with HIV attending clinical care in Kenya, Namibia and Tanzania. J Fam Plann Reprod Health Care. 2015;41(1):e1. https://dx.doi.org/10.1136%2Fjfprhc–2013–100784.
39.Carey MP, Schroder KE. Development and psychometric evaluation of the brief HIV Knowledge Questionnaire. AIDS education and prevention. 2002;14(2):172–82. http://dx.doi.org/10.1521/aeap.14.2.172.23902.
40.Napper LE, Fisher DG, Reynolds GL. Development of the perceived risk of HIV scale. AIDS Behav. 2012;16(4):1075–83. https://doi.org/10.1007/s10461–011–0003–2.
41.Shaweno D, Tekletsadik E. Validation of the condom use self-efficacy scale in Ethiopia. BMC Int Health Hum Rights. 2013;13(1):22. https://doi.org/10.1186/1472–698X–13–22.
42.Pulerwitz J, Gortmaker SL, DeJong W. Measuring sexual relationship power in HIV/STD research. Sex roles. 2000;42(7–8):637–60. https://doi.org/10.1023/A:1007051506972.
43.Samandari G, Speizer IS, O’Connell K. The role of social support and parity in contraceptive use in Cambodia. Int Perspect Sex Reprod Health.2010;36(3):122–31. https://doi.org/10.1363/ipsrh.36.122.10.
44.Twisk J BL, Hoekstra T, Rijnhart J, Welten M, Heymans M. Different ways to estimate treatment effects in randomised controlled trials. Contemp Clin Trials Commun. 2018;10:80–5. https://dx.doi.org/10.1016%2Fj.conctc.2018.03.008.
45.Kolamunnage-Dona R, Powell C, Williamson PR. Modelling variable dropout in randomised controlled trials with longitudinal outcomes: application to the MAGNETIC study. Trials.2016;17(1):222. https://dx.doi.org/10.1186%2Fs13063–016–1342–0.
46.Lapping K, Marsh DR, Rosenbaum J, Swedberg E, Sternin J, Sternin M, et al. The positive deviance approach: challenges and opportunities for the future. Food Nutr Bull. 2002;23(4) Suppl 2:128–35. https://doi.org/10.1177/15648265020234S217.